New: Maxis AI Workforce now live across clinical operations.Learn more →

Maxis AI — THE FIRST AI WORKFORCE IN CLINICAL TRIALS
EventsPanel

Event

DIA Global Annual Meeting 2026

Maxis AI panel: 'Governed AI in Submissions.'

Location

Venue announced upon registration

Dates

June 14–18, 2026

Time

9:00 AM – 5:00 PM local time

DIA Global Annual Meeting 2026

About this event

Maxis AI panel: 'Governed AI in Submissions.' Join the Maxis AI team and industry peers for a focused session on how governed agentic AI is reshaping clinical operations, biometrics, and oversight across regulated R&D.

Expect live demos, working sessions with our architects, and conversations with sponsors and CROs who have moved beyond pilots into production.

Key takeaways

  • Live demos of agentic CDM, biometrics, and oversight in production.
  • Benchmarks on cycle time, cost, and quality from peer sponsors and CROs.
  • Direct conversations with Maxis AI architects and clinical SMEs.
  • A clear view of where governed AI fits across your operating model.
  • Curated networking with R&D, clinical, biometrics, and QA leaders.

Meet the team

Dr. Anika Rao

James O'Connell

VP, R&D Economics

James writes about the financial mechanics of clinical trials and where AI moves the needle on per-study burn rate and submission timelines.

Marcus Lehmann

James O'Connell

VP, R&D Economics

James writes about the financial mechanics of clinical trials and where AI moves the needle on per-study burn rate and submission timelines.

Priya Natarajan

James O'Connell

VP, R&D Economics

James writes about the financial mechanics of clinical trials and where AI moves the needle on per-study burn rate and submission timelines.

James O'Connell

James O'Connell

VP, R&D Economics

James writes about the financial mechanics of clinical trials and where AI moves the needle on per-study burn rate and submission timelines.

Maxis AI Newsroom

James O'Connell

VP, R&D Economics

James writes about the financial mechanics of clinical trials and where AI moves the needle on per-study burn rate and submission timelines.

Location

Venue announced upon registration

Full venue details, travel guidance, and on-site logistics will be shared with all registered attendees ahead of the event.

Who should attend

  • Heads of Clinical Operations, Data Management, and Biometrics
  • R&D, Clinical Development, and Portfolio leaders
  • QA, Compliance, and Validation leaders responsible for GxP oversight
  • Sponsor and CRO executives evaluating agentic delivery models

Why attend

See governed agentic AI working against real clinical workflows.

Benchmark your program against peers from Top-20 pharma and CROs.

Meet the Maxis AI team and explore tailored deployment paths.

Leave with a point of view you can take back to your leadership team.

Looking for AI Workforce for clinical trials?

Explore our AI Workforce Platform

See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.